Anti-HIV activity in traditional Chinese medicine: clinical implications of monomeric herbal remedies and compound decoctions

With the global spread of human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS), the pursuit of potent treatments has ascended as a paramount concern in global healthcare. Traditional Chinese medicine (TCM) has been used for thousands of years in China and other East Asian countries and it offers remedies for an extensive array of ailments, including HIV and AIDS. This review focuses on the clinical significance of single herbs and composite tonics in TCM with antiviral activity against HIV. Initially, the anti-HIV activity of single herbs was analyzed in detail. Many herbs have been shown to have significant anti-HIV activity. The active ingredients of these herbs exhibit their anti-HIV effects through various mechanisms, such as inhibiting viral replication, preventing viral binding to host cells, and interfering with the viral lifecycle. Furthermore, we delved into the clinical significance of HIV-associated formulations provided as a result of Chinese compound prescription. These combinations of herbal ingredients are designed to amplify therapeutic efficacy and minimize adverse effects. Clinical trials have demonstrated the therapeutic benefits of these prescriptions for individuals infected with HIV. The intricate composition of these prescriptions potentially augments their anti-HIV activity through synergistic effects. Additionally, this review underscores the clinical importance of TCM in the context of HIV treatment. While numerous herbs and prescriptions exhibit anti-HIV activity, their safety and efficacy in clinical applications warrant further investigation. When combined with contemporary antiretroviral drugs, TCM may serve as an adjunctive therapy, assisting in reducing side effects, and enhancing patients' quality of life. To optimally harness these natural resources, further exploration is imperative to ascertain their efficacy, safety, and optimal utilization, thereby offering a broader spectrum of therapeutic options for HIV-afflicted individuals.

1 Introduction

Acquired immunodeficiency syndrome (AIDS), a potentially fatal infectious ailment, is caused by the human immunodeficiency virus (HIV), which results in a debilitating compromise of the host's immune system. Consequently, a cascade of opportunistic infections or malignancies ensues, ultimately resulting in mortality for those afflicted (1, 2). The Joint United Nations Programme on HIV/AIDS predicted that, by the end of 2022, 39 million patients would be affected with HIV/AIDS globally, with 1.3 million novel HIV infections reported during that year (3).

The primary targets of HIV are CD4+ T lymphocytes, which play a pivotal role in the immune response against microbial antigens (4). Following viral invasion, the envelope protein Gag, specific to the first domain of CD4 surface marker molecules, orchestrates an onslaught against CD4+ T cells, precipitating a precipitous decline in their numbers (5). Consequently, HIV embarks on a brief but potent replication period, initiating early damage to the host immune system. Owing to its swift progression, formidable challenges, grave repercussions, and wide-ranging effects, HIV/AIDS has emerged as a pivotal public health challenge.

Acquired immunodeficiency syndrome is an immunological disease that poses an immense global threat to human wellbeing. Although conventional highly active antiretroviral therapy (HAART) has achieved remarkable progress in viral suppression and immune augmentation, its side effects and long-term therapeutic impact remain non-negligible. Against this backdrop, traditional Chinese medicine (TCM), which has a venerable history in healthcare systems, is gaining increasing recognition. In the treatment of AIDS, TCM therapies have demonstrated the potential to alleviate clinical symptoms, enhance immune function, and prolong the onset of increased severity of the disease. As a result, research institutions and experts have begun to delve deeper into TCM therapies for HIV, adopting rigorous scientific methodologies to probe its pharmacological mechanisms, efficacy, and possible side effects. Several herbal remedies have yielded positive results in clinical practice, providing useful case studies on the application of herbal medicines in HIV therapy.

Recent advances into herbal treatments for HIV have included a series of breakthroughs, encompassing the screening of diverse herbs and the identification of antiviral active constituents. Herbal screening has increasingly focused on discovering plants that exhibit pronounced anti-HIV activity. Through systematic pharmacological evaluations and laboratory research, several herbal extracts of plants have been identified as potent HIV inhibitors. These herbal extracts likely suppress viral replication and invasion mechanisms. Furthermore, some studies have unveiled the potential of herbs to inhibit key enzyme activities, such as HIV reverse transcriptase. Identification of active constituents is a pivotal aspect of herbal medicine research as it provides a more precise understanding of anti-HIV mechanisms.

Moreover, herbal medicines have the potential for immune modulation; HIV infection severely undermines the immune system of the body, rendering it ineffective against viruses. Hence, studies have explored the potential of herbs to enhance immune function. Some herbs augment immune cell activity, stimulate cytokine secretion, facilitate the restoration of immune homeostasis, and bolster resistance. In addition to laboratory investigations, the number of clinical trials investigating the efficacy of herbal medicines in HIV treatment has increased. Herbal formulations have been integrated into clinical practice, resulting in positive outcomes. Researchers have evaluated the effects of herbal medicines in randomized controlled trials to assess the improvements in clinical symptoms, CD4+ T cell counts, and viral load control. These endeavors have engendered novel perspectives and possibilities for the application of herbal medicines in HIV therapy.

2 Monomeric herbal remedies and extracts for HIV treatment

Traditional Chinese medicine derives its ingredients from various sources, including plants, animals, and minerals; of these, plants are the most commonly used. Plant-derived medicines are the most extensively researched category in anti-HIV therapies within TCM. The active chemical components of notable anti-HIV herbs in TCM are listed in Figure 1.

Figure 1

Figure 1. Constituents with anti-HIV activity that are present in single herbs.

2.1 Licorice

Licorice, a solitary herbal remedy within TCM, is commonly used as an HIV treatment in clinical settings, featuring prominently as an additive in herbal formulations. The effective chemical constituents of licorice, such as glycyrrhizic acid, glycyrrhizin, glycyrrhetinic acid, and their derivatives exhibit a pronounced ability to inhibit viral replication and effectively eliminate dormant viruses, thus demonstrating a broad-spectrum antiviral effect (6). Glycyrrhizin is primarily found in the roots of licorice and has immune-activating properties (7). Glycyrrhizin potentially lowers membrane fluidity and inhibits intercellular viral infections. Harada (8) demonstrated that cells treated with glycyrrhizin exhibit time-dependent increases in membrane fluidity and sensitivity to infection and fusion when placed in a glycyrrhizin-free replacement culture medium, providing evidence for a close association between membrane fluidity and viral infection. Sasaki et al. (9) found that glycyrrhizin induced β-chemokine production in peripheral blood mononuclear cell (PBMC) cultures from patients infected with HIV, thus inhibiting the entry of NSI-HIV. Ninety percent of HIV replication was inhibited in 31% of the samples. Researchers from China (10) discovered that glycyrrhizin supplementation (100 mg/kg/day) protected rats against R5-type HIV-1 gp120 damage by safeguarding rat myocardial function while maintaining normal rat body weight, lipid metabolism, and antioxidant metabolism. Japanese researchers (11) have extracted phenolic components from glycyrrhizin, which enhance its antagonistic effect against HIV in ATL-IK cells. Two novel glycyrrhizin derivatives inhibited HIV proliferation at low concentrations. In addition, a neutral water-soluble polysaccharide, glycyrrhiza polysaccharide (GPS), was isolated from the glycyrrhiza residue and exhibited a 36.2% inhibition rate against HIV (12).

2.2 Arnebia euchroma

Studies since the 1990s revealed that Arnebia euchroma, an important medicinal plant in Xinjiang, exhibited robust anti-HIV activity. Kashwada et al. (13) established the potent anti-HIV-1 activity of hot-water extracts from dried A. euchroma roots, especially a 70% aqueous ketone extract, which displayed effectiveness against HIV replication in H9 cells during acute infection. Sodium and potassium salts of caffeic acid tetramers from A. euchroma were identified as active components. Chen et al. (14) discovered that Shikonin inhibits chemokine-induced leukocyte migration and monocyte chemotaxis while reducing leukocyte calcium influx. Shikonin significantly downregulated the mRNA expression of the HIV-1 co-receptor CCR5, inhibiting HIV-1 replication, suggesting that the anti-HIV-1 action of Shikonin is related to interference with chemokine receptor expression and function. Maierdan et al. (15, 16), extracted a water-soluble component from A. euchroma that protected MT-2 cells against HIV-1 infection and inhibited HIV-1 integrase (HIV-1 IN) activity. A. euchroma polysaccharide, another active component, possesses immune-enhancing properties and enhances the diminished proliferative response of splenic lymphocytes in immunosuppressed mice, having immunomodulatory effects (17).

2.3 Isatis tinctoria

Isatis tinctoria, known for its pronounced immune-regulating and broad-spectrum antiviral effects, began to garner research attention in the late 20^th century. Chang and Yeung (18) demonstrated that extracts from I. tinctoria completely inhibited HIV growth in H9 cells at sub-toxic concentrations, establishing that they can effectively block HIV replication in a dose-dependent manner. Ngan et al. (19) found that dimethyl sulfoxide (DMSO) extracts of I. tinctoria effectively inhibited HIV-1 in vitro. I. tinctoria extracts did not induce interferons or inactivate extracellular HIV or herpes simplex virus; they specifically inhibited HIV but not herpes simplex virus. These studies reported the anti-HIV activity of I. tinctoria; however, failed to identify the active compounds. Wang et al. (20) characterized cyclic peptides in I. tinctoria and identified five novel and three known cyclic peptides. Some of these peptides displayed anti-HIV activity, with cyclolinopeptide Y5 being the most effective according to testing with an XTT-based in vitro anti-HIV assay.

2.4 Honeysuckle

The antiviral efficacy of honeysuckle has been validated in numerous experimental and clinical studies. Compounds isolated from honeysuckle, such as 3,5-O-dicaffeoylquinic acid and 3,5-O-dicaffeoylquinic acid methyl ester, exhibit strong inhibitory effects on HIV-1 reverse transcriptase and HDNAP-γ. At concentrations 1–6 μM, all dicaffeoylquinic acids inhibited HIV-1 replication in T-cell lines (21). Other studies have identified 13 additional caffeoylquinic acids, caffeic acids, and caffeic acid methyl esters in honeysuckle, all of which have demonstrated antiviral activity against respiratory viruses (22).

2.5 Astragalus

Astragalus, renowned for its wide-ranging antiviral and immunomodulatory properties (23, 24), contains compounds such as astragaloside, astragaloside IV, and astragalus polysaccharide, all of which have antiviral effects. Studies on the inhibitory effects of astragaloside on HIV-1 demonstrated that both astragaloside and isoastragaloside I have an inhibitory effect on HIV-1 infection. At a concentration of 50 g/mL, isoastragaloside I exhibited noticeable inhibition of virus infection that was lower than the effective concentration of astragaloside I at 100 g/mL. Furthermore, astragaloside and isoastragaloside I inhibit the integration of viral DNA into the host cell genome (25).

2.6 Huangcen

Huangcen is a popular TCM material that is used to treat HIV. Studies on the antiviral effects of Huangcen have focused on its molecular mechanism (26). Huangcen extract contains two flavonoid compounds, baicalein and baicalin, which inhibit HIV infection and replication (27). They suppress various stages of HIV-1 replication, including viral entry into cells, viral protease activity, and reverse transcriptase activity (28). With more than 90% inhibition when present at 2 μg/mL, baicalein was the first compound to be reported to effectively inhibit reverse transcriptase activity of murine leukemia virus and HIV. Baicalein exhibited high specificity for reverse transcriptase (29). According to Chen (30), baicalein inhibited HIV-1 in H9 cell cultures with chronic HIV-1 infection, suppressing the activity of HIV-1 reverse transcriptase and cytopathic effects as well as inhibiting viral immunofluorescent and P24 antigens. Li et al. (31) discovered that the anti-HIV-1 activity of baicalin was also observed in primary human PBMC cultures infected with HIV-1 in vitro and that baicalin significantly inhibited the replication of HIV-1 in a dose-dependent manner (32). Furthermore, Li et al. (33) found that baicalein at non-cytotoxic concentrations inhibited the fusion of cells expressing CD4+/CXCR4 or CD4+/CCR5 with X4 and R5 HIV-1 Env proteins, respectively. Additionally, baicalein blocked the initial stage of HIV-1 adsorption, preventing the early termination of DNA replication within cells. In a study by Wang et al. (34), the in vitro anti-HIV-1 activity of the baicalein-zinc (BA-Zn) complex was compared with that of baicalein and BA-Zn. The results showed that, compared to those of baicalein, BA-Zn had lower cytotoxicity and higher anti-HIV-1 activity. Using electrochemical methods, Sun et al. (35) studied the interaction between baicalein and DNA and speculated that baicalein binds to DNA through intercalation.

2.7 Salvia miltiorrhiza

Salvia miltiorrhiza is a widely used TCM material. In 1996, Chen et al. (36) discovered that S. miltiorrhiza extracts had anti-HIV and anti-HBV activities. The water-soluble components of S. miltiorrhiza are its major active ingredients, which contain more than 20 distinct monomeric compounds. All compounds possess strong antioxidant properties, with the highest content and activity found in salvianolic acid A and salvianolic acid B (37). Abd-Elazem et al. (38) isolated and purified two water-soluble compounds, M522 and M532, from S. miltiorrhiza. High concentrations of these compounds exhibited no cytotoxicity in H9 cells and they were not able to prevent HIV from entering H9 cells or inhibit reverse transcriptase activity in infected cells. However, they strongly inhibited acute HIV-1 infection in H9 cells. Qin et al. (39) isolated four compounds from S. miltiorrhiza, including a novel compound and demonstrated anti-HIV activity of the compounds against HIV-1 integrase and HIV-1 reverse transcriptase. Zhang et al. (40) discovered three novel polyphenolic derivatives in S. miltiorrhiza water extracts, tested their anti-HIV-1 activity by inhibiting the P24 antigen in MT-4 cells that were infected with HIV-1, and tested their HIV-1 reverse transcriptase activity. Mori et al. (41) found that lithospermic acid, derived from S. miltiorrhiza, exhibited strong inhibitory effects on nucleocapsid protein (NC) without spontaneous oxidation. Given that HIV-1 NC is an ideal target for antiretroviral therapy, these results position it as a promising starting point for developing highly effective NC inhibitors.

2.8 Herba Andrographis

Herba Andrographis is a TCM material with notable anti-inflammatory and antiviral properties. Current research on Herba Andrographis primarily focuses on its components, including lactones, neochuanxinlian lactones, deoxychuanxinlian lactones, and dehydrochuanxinlian lactones (42). Dehydrochuanxinlian lactone succinate (DASM), isolated from Herba Andrographis lactones, inhibited HIV in vitro. In a previous study, DASM prevented HIV-induced cell fusion and HIV binding to H9 cells (43). Ma et al. (44) discovered that rat serum containing Herba Andrographis reduced the activity of CXCR4 and CCR5 promoters in H9 cultured cells in vitro. In human studies, Herba Andrographis reduced the surface expression of CXCR4 and CCR5 in peripheral blood CD4+ T lymphocytes, indicating its anti-HIV-1 activity. Mayur et al. synthesized a series of derivatives of Herba Andrographis lactones. One compound (compound 9) displayed a high therapeutic index and inhibited HIV-1 infection by blocking gp120-CD4+/CXCR4/CCR5 interactions. These compounds have been suggested to bind to the V3 loop of the HIV-1 envelope protein gp120. All these studies demonstrated the potential of Herba Andrographis and its derivatives as anti-HIV drugs (45).

2.9 Ganoderma

Ganoderma has been used for medicinal purposes for more than 2,000 years. Ganoderma is assumed to possess immunomodulatory, antiviral, anti-tumor, anti-aging, and hypoxia tolerance-enhancing activities (46, 47). In addition to Ganoderma extracts, polysaccharides and triterpenoids have been the subject of studies on Ganoderma's antiviral properties. Kim et al. (48) extracted two components of different molecular weights from Ganoderma fruiting bodies and observed that the low-molecular-weight component strongly inhibited the cytopathic effects of HIV-1 on CEM cells. El-Mekkawy et al. (49) isolated multiple triterpenoid compounds from methanol extracts of Ganoderma fruiting bodies. Among these compounds, ganoderiol F and ganodermanontriol exhibited anti-HIV-1 activity. Both compounds had inhibition concentrations of 7.8 μg/mL, while ganoderic acid B, ganoderiol B, ganoderic acid C1, 3β-5α-dihydroxy-6β-methoxyergosta-7,22-diene, ganoderic acid α, ganoderic acid H, and ganoderiol A showed moderate inhibitory activity against HIV-1 protease, with an IC₅₀ of 0.17 ± 0.23 mM. Min et al. (50) isolated triterpenoid compounds, including Ganodermaol A and ganoderic acid β, from Ganoderma fruiting bodies and noticed that ganoderic acid β, lucidumol B, ganoderic acid C1, 3β-5α-dihydroxy-6β-methoxyergosta-7,22-diene, ganoderic acid α, ganoderic acid H, and ganoderiol A exhibited significant anti-HIV-1 protease activity with IC₅₀ values ranging from 20–90 μM. Devinna et al. (51) investigated the reaction of Ganoderma triterpenoid compounds with HIV-1 aspartic proteinase and fibrinolysin I and observed that ganoderic acid B showed the highest affinity for HIV-1 proteinase, further confirming the anti-HIV activity of Ganoderma. Cheng et al. (52) found that Ganoderma antler-shaped fruiting bodies had a higher inhibition percentage (54.3% ± 6.2%) and higher cytotoxicity (CC₅₀ <300 ppm) compared to Ganoderma crude extract at 150 ppm.

2.10 Polygonum cuspidatum

Polygonum cuspidatum is used in a wide range of clinical applications in TCM, with its rhizomes as the key medicinal component. Recently, notable progress has been made in understanding its pharmacological activities, including its lipid-lowering, anti-inflammatory, anti-shock, antioxidant, anti-HIV-1, antimicrobial, and hepatoprotective effects. Schinazi et al. (53) demonstrated that anthraquinone compounds found in P. cuspidatum possess anti-HIV activity, with emodin exhibiting an IC₅₀ of 36.3 μmol/L against HIV-1. Jiang (54) infected MT-4 cells with HIV and then treated them with a P. cuspidatum water extract to observe HIV-1 proliferation. Continuous mixing of infected cells with uninfected cells, along with the addition of the P. cuspidatum water extract, completely inhibited giant cell formation. These results suggest that the extract acts on the surface of the virus to prevent its attachment to the cells. The water extract of P. cuspidatum had an inhibitory effect on the binding of recombinant gp120 to CD4, suggesting that one of the mechanisms of its anti-HIV-1 activity is the prevention of virus attachment to cells. Additionally, Jiang et al. (55) found that a 10% P. cuspidatum water extract effectively inhibited the binding of HIV-1 surface gp120 to CD4 on cell surfaces in vitro, partially inhibiting splenomegaly, immune suppression, and viremia in AIDS mice. Furthermore, P. cuspidatum extract was demonstrated to significantly inactivate HIV-1 reverse transcriptase in vitro, suggesting that its antiviral effect may be related to enzyme inactivation. According to Lin et al. (56), a 70% ethanol extract of P. cuspidatum had an inhibitory effect on HIV-1-induced syncytium formation in vitro at non-cytotoxic concentrations, with an EC₅₀ of 13.94 ± 3.41 μg/mL.

2.11 Prunella vulgaris

Prunella vulgaris is a commonly used TCM in clinical practice that exhibits antiviral and immunosuppressive activities. It contains various chemical components beneficial for human health and its active ingredients have been the subject of increasing research. Yao et al. (57) found that a purified P. vulgaris extract effectively inhibited HIV-1 replication in the lymphocyte cell line MT-4, monocyte cell line U937 and peripheral blood monocytes at concentrations of 6, 30, and 12.5 μg/mL, respectively. The extract also blocked cell-to-cell transmission of HIV-1 and interfered with the binding of HIV-1 and purified gp120 to CD4. Overall, the purified P. vulgaris extract antagonizes HIV-1 infection in susceptible cells by preventing the virus's attachment to the CD4 receptor. According to Kageyama et al. (58), P. vulgaris extract inhibits HIV reverse transcription replication in vitro and the active components can be detected in the plasma after oral administration, demonstrating its feasibility for oral administration. Liu et al. (59) screened P. vulgaris extracts from various traditional Chinese herbs and found that they exhibit strong antiviral activity and effectively inhibit HIV-1 gp41 six-helix bundle activity. Zhang (60) studied HIV-1-infected PBMCs induced with P. vulgaris polysaccharides and investigated their levels of apoptosis and the cytokines IL-2 and IL-4. The IL-2 levels in HIV-infected PBMC were significantly lower than those in the healthy control group, indicating that P. vulgaris polysaccharides could increase IL-2 levels in HIV-infected individuals and partially correct abnormal immune function. Oh et al. (61) found that, compared to the ethanol extract, the water extract of P. vulgaris exhibited stronger antiviral activity, and the inhibition of the HIV-1 virus mainly occurred through interference with early and post-virus binding events, suggesting that these extracts have potential as antiviral agents against HIV-1.

Since the extensive research of developing anti-HIV drugs has been conducted, more and more TCM have been found to have significant or potential treatment efficacy. Among them, the extracts or active monomer components of TCM have been reported to have various effects; the mechanisms of these effects have mainly been attributed to inhibiting HIV transcription and replication, blocking HIV binding to host cells, or reducing the expression of CD4+ T cell surface receptors. Although there is a lot of research in this field, few reports have compared the effects of different TCM extracts or active monomer components, which will become the focus of future research. Researchers are more concerned about the effects of mixture which consist of different TCM extracts or active components. Perhaps they believe that using them alone may not be fully functional, and the mixing effects are better, which is also in line with the concept of TCM compatibility. Below, we will discuss the research on mixed medication.

3 Therapeutic efficacy of compound decoctions on HIV

Compound decoctions, a form of TCM herbal preparations, have garnered attention recently for the treatment of patients with HIV/AIDS. Several clinical trials have assessed the efficacy of compound decoctions in controlling HIV infection, improving immune function, and enhancing the quality of life of patients. These clinical trials typically employ a double-blind, randomized, placebo-controlled approach in which patients are divided into groups receiving compound decoctions and placebo. The observations included changes in clinical symptoms, viral load, CD4+ T lymphocyte counts, and other relevant indicators. Preliminary findings suggest that some compounded tonics may be more effective in suppressing HIV, improving immune function of patients and alleviating symptoms. Clinical data on compounded tonics that have been shown to be effective in suppressing HIV are listed in Table 1. The distribution of the duration of the clinical diagnosis in the study population was also determined (Figure 2).

Table 1

Table 1. Clinical data on compounded tonics with a more significant effect on HIV viral suppression.

Figure 2

Figure 2. Distribution of the duration of clinical diagnosis for the study population.

3.1 Yi Ai Kang capsules

Yi Ai Kang capsules contain an herbal formulation with a rich composition, including ginseng, Astragalus, Ligusticum wallichii, fried atractylodes, Rehmannia, Ophiopogon, Poria cocos, Angelica sinensis, peony, scutellaria, and licorice, endowing them with various pharmacological properties such as invigorating Qi, fortifying the spleen, nourishing Yin, dispelling wind and heat, and detoxifying dampness (157). Recently, numerous clinical studies have confirmed the potential efficacy of Yi Ai Kang capsules in treating patients with AIDS, particularly those with lung-spleen Qi deficiency syndrome (65–69). In addition to improving clinical symptoms and signs, they reduce the incidence of opportunistic infections, stabilize viral loads, increase CD4+ T lymphocyte counts, prolong patient survival, and lower mortality rates (62–70, 157, 158).

According to Li et al. (62), Yi Ai Kang capsules, in conjunction with traditional Chinese syndrome differentiation treatment, notably improved clinical symptoms and signs, reduced viral load, increased CD4+ T lymphocyte counts, and decreased the occurrence of opportunistic infections. Zhang (65) also employed a combination of Yi Ai Kang capsules and traditional Chinese syndrome differentiation treatment, suggesting that the mechanism of improving immune function in patients may involve blocking the PD-1 and ID2/E2AmRNA signaling pathways, thereby enhancing immune function. The clinical expert group of the Henan Provincial Traditional Chinese Medicine AIDS Treatment emphasizes that intervention with Yi Ai Kang capsules in patients with HIV can stabilize or slow the decline in CD4+ T lymphocytes, reduce viral loads, enhance quality of life, and extend survival (59). Yang (64) pointed out that combining Yi Ai Kang capsules with HAART can improve quality of life by alleviating clinical symptoms and increasing CD4+ T lymphocyte counts. Research by Wang (66) demonstrated that combining Yi Ai Kang capsules with HAART is more advantageous than HAART monotherapy for immune reconstitution in patients with poor immune function (lung-spleen Qi deficiency syndrome). Furthermore, Zhang et al.'s study (70) suggests that combining Yi Ai Kang capsules with a cough-relieving formula effectively improves cough symptoms in patients, achieving an overall efficacy rate of 93.75%. The Yi Ai Kang capsules also exhibit the potential to regulate immune functions. According to research by Liu et al. (67), the Yi Ai Kang capsules promote a balanced ratio of Th17/Treg cells, effectively regulate the disruption of the gut microbiota, and enhance immunity. Li et al. (68) found that Yi Ai Kang can improve the expression of helper receptors and abnormal cell activation levels in patients with AIDS, thereby mitigating immune damage following HIV infection. Zhao et al. (159) demonstrated the regulation of immune function by a combined treatment of Yi Ai Kang capsules combined with IPVr, promoting the differentiation of CD4+ T cells into CD4Tcm cells. Additionally, Xu (69) revealed that Yi Ai Kang capsules can reduce viral replication and immune damage by modulating the NF-κB signaling pathway.

3.2 Aikeqing capsules

Aikeqing capsules, a TCM herbal compound, contain various medicinal herbs, including P. vulgaris, Scutellaria baicalensis, S. miltiorrhiza, Epimedium, P. cuspidatum, Astragalus membranaceus, Glycyrrhiza uralensis, Eucommia ulmoides, Lithospermum erythrorhizon, and Atractylodes macrocephala. These capsules possess the therapeutic properties of heat clearing, detoxification, kidney tonification, Qi enhancement, improving blood circulation, and stasis removal. Aikeqing capsules have various applications in the treatment of patients with HIV/AIDS who have spleen and kidney deficiencies, as well as lingering pathogenic factors, to ameliorate clinical symptoms and enhance the quality of life. With advances in clinical research, numerous studies have confirmed the therapeutic efficacy of Aikeqing capsules in the treatment of patients with HIV/AIDS. This paper provides a brief overview and analysis of the representative studies to serve as a reference for exploring the efficacy of Aikeqing capsules in HIV treatment.

The effectiveness of Aikeqing capsules for the treatment of HIV/AIDS has been validated in multiple clinical studies. Li and Zuo (71, 72) demonstrated that prolonged use of Aikeqing capsules alone can stabilize and elevate CD4+ T lymphocyte counts in patients with HIV, especially for those with CD4+ T counts in the range of 200 to 350 cells/μL. Cao and Dong et al. (73, 74) combined Aikeqing capsules with HAART treatment for over 12 months and demonstrated improved CD4+ T lymphocyte counts and ameliorated clinical symptoms compared with those of HAART monotherapy. Furthermore, Wang et al. examined the effect of Aikeqing capsules on post-HAART inflammation in patients with HIV/AIDS from the perspective of ADAM17. Although there were no significant differences in certain indicators, this study highlights the regulatory role of Aikeqing capsules (75). In summary, Aikeqing capsules demonstrated potential efficacy in the treatment of patients with HIV/AIDS. They can stabilize and elevate CD4+ T lymphocyte counts, ameliorate clinical symptoms, enhance quality of life, and show a certain level of safety for use. Further large-scale clinical trials are required to validate the precise efficacy and mechanism of action of Aikeqing Capsules for the treatment of HIV/AIDS.

3.3 Fuzheng Paidu pills

Fuzheng Paidu pills are compound Chinese herbal medicines containing ingredients such as A. membranaceus, Panax notoginseng, Ligustrum lucidum, Cornus officinalis, Hedyotis diffusa, Forsythia suspensa, A. macrocephala, Saposhnikovia divaricata, and G. uralensis (76). They have properties of replenishing Qi and nourishing Yin, clearing heat, and causing detoxification. They have demonstrated significant efficacy in clinical applications and are available as mature formulations. Fuzheng Paidu pills improve symptoms and signs of “deficiency of righteous Qi and lurking pathogenic factors” in asymptomatic individuals infected with HIV (160). They increase or stabilize CD4 cell counts in infected individuals and reduce the viral load. This medication improves the overall quality of life of infected individuals and has been safely administered in clinical practice. Furthermore, Fuzheng Paidu pills regulate the human immune system, enhance body resistance, and alleviate patient discomfort.

Peng and Wang (77) found that Fuzheng Paidu Pills maintain the stability of CD4+ T cell counts in patients with an effective rate of 82.69%, significantly improving clinical symptoms and enhancing immune function. Similarly, Liu (78) demonstrated a decrease in major symptoms of a patient to varying degrees after treatment with Fuzheng Paidu pills, with a treatment effectiveness rate of 91.3% for viral load reduction. Multiple studies have revealed the mechanisms of action of Fuzheng Paidu pills in HIV/AIDS treatment. According to Jiang et al. (80), Fuzheng Paidu pills upregulate IFN-α expression by regulating the interaction between CD40 and CD40L, thereby enhancing antiviral and immune-regulatory functions. Additionally, Peng et al. (161) demonstrated that Fuzheng Paidu pills enhanced the phagocytic function of peritoneal macrophages in immunosuppressed mice, promoted the formation of hemolysin, and increased the transformation of peripheral blood lymphocytes. Tan suggested that Fuzheng Paidu pills increase CD4 + T lymphocyte counts, stabilize viral load, and protect liver function when used to treat HIV/HCV co-infection (79). Shi et al. (162) further revealed that these pills significantly increase CD3+ and CD4+ cell counts in immunosuppressed mice, elevate the CD4+/CD8+ ratio, and improve overall immune function. In summary, Fuzheng Paidu pills have exhibited significant efficacy in the treatment of HIV/AIDS. They increase or stabilize CD4+ cell counts, ameliorate clinical symptoms, enhance quality of life, and possess a certain degree of immunoregulatory and antiviral activity.

3.4 Ailing Granules

Ailing Granules, a traditional Chinese herbal compound, mainly consist of ingredients such as A. membranaceus, S. baicalensis, and Persica. These granules possess the medicinal properties of primarily targeting symptoms of Qi deficiency and blood stasis while also tonifying Qi, nourishing Yin, promoting blood circulation, and detoxifying (81, 88, 90). They are used in the clinical treatment of patients with HIV/AIDS who exhibit a combination of deficiencies and excess syndromes, providing a holistic approach to restoring health. This article provides a comprehensive analysis of multiple clinical studies to explore the composition, therapeutic effects, specific indications, and clinical treatment outcomes of Ailing Granules, providing a reference for the application of traditional Chinese medicine in HIV/AIDS treatment.

Several clinical studies have explored the application and therapeutic effects of Ailing Granules in HIV/AIDS treatment. In a study by Liu (81), Ailing Granules, when used in conjunction with HAART for long-term treatment of patients with HIV/AIDS who had Qi deficiency and blood stasis, improved clinical symptoms and signs, increased CD4+ T lymphocyte counts, enhanced immune function, and did not compromise the effectiveness of the antiretroviral therapy. Multiple studies conducted by Jian'an also demonstrated that Ailing Granules control the increase in viral load (82, 84, 86), inhibit HIV-1 virus replication (86, 87), increase CD4+ T lymphocyte counts (82, 85, 87), improve patient symptoms and signs (84), enhance immune function (83, 84, 87), and stabilize HIV-infected individuals (82–88). In research focusing on patients with HIV/AIDS who have Qi deficiency, blood stasis, and lingering pathogenic factors, Ailing Granules also exhibited significant therapeutic effects (88). According to Song et al. (89), Ailing Granules might influence the progression of AIDS by restoring CD4+ T cell counts, enhancing their IFN-γ secretion capacity, and reducing CD8+ T cell secretion of IL-4, thereby rebalancing Th1 and Th2 cytokines. Jin (90) indicated that Ailing Granules, in combination with HAART, promoted the secretion of IFN-α by MDC and PDC, thereby improving patient immune function. This finding was also supported by other studies (81–83). According to Chen et al. (91), in individuals infected with HIV, Ailing Granules could, to some extent, delay the shift of Th1-type cells to Th2-type cells, rebalancing Th1 and Th2 cytokines. According to multiple studies, Ailing Granules increase CD4+ T cell counts, enhance immune function, and stabilize the viral load. Some studies have focused on patients with Qi deficiency and blood stasis, while others have included many types of patients with HIV/AIDS. These differences could have an impact on the specificity and generalizability of the results.

3.5 Kangai capsules

Kangai capsules comprise 21 TCM herbs, including Viola yedoensis, S. baicalensis, Morus alba bark, P. vulgaris, Isatis indigotica, Panax ginseng, A. membranaceus, Dioscorea oppositifolia, and P. cocos. These herbs contain multiple active ingredients and exhibit various pharmacological actions, including immune regulation, anti-inflammation, and antioxidation. Kangai capsules have been demonstrated in multiple studies to improve HIV/AIDS treatment primarily by increasing CD4+ T cell counts (95–106), controlling viral load (96, 103, 105), and enhancing immune function (95, 99, 101). Wang et al. (95) found that Kangai capsules significantly improved CD4+ T cell counts in patients, aiding in maintaining immune function. According to Li (97), Kangai capsules combined with HAART increased CD4+ T cell numbers, improved immune function, alleviated the extent of venous dilatation, and lowered the levels of inflammatory factors. These studies demonstrated the positive effects of Kangai capsules in improving the immune status of patients with HIV/AIDS. He et al. (101) observed that the combination therapy of HAART with Kangai capsules reduced plasma viscosity and improved inflammatory factor levels in patients. Clinical studies have shown that Kangai capsules do not exhibit significant peripheral blood cell toxicity (104) and may even protect kidney function (103). In clinical observations conducted by Ba (106), for HIV-infected individuals with inherent factors of dampness and Qi-Yin deficiency, Kangai capsules improved symptoms and signs at the T-cell level. Kangai capsules have exhibited a positive impact on CD4+ T cell counts, immune function, viral load, and quality of life in different studies (95, 96, 98, 100, 102). Furthermore, some studies have explored the application of Kangai capsules in different patient groups, such as intravenous drug users and those with sexually transmitted infections (99), providing novel directions for further research. In summary, Kangai capsules demonstrated significant efficacy and potential for HIV/AIDS treatment. Their mechanisms of action may involve immune regulation, anti-inflammation, and antioxidation, involving multiple pathways.

3.6 Aifukang capsules

Aifukang capsules, a TCM preparation, have shown unique therapeutic effects and potential for HIV/AIDS treatment. Aifukang capsules are composed of traditional Chinese herbs, including S. baicalensis, Lonicera japonica, Clematis chinensis, Herba Lycopi, Cortex Fraxini, and P. cuspidatum. These ingredients have functions such as clearing heat, detoxifying, promoting blood circulation, and removing obstructions in the meridians. Wu et al. (107) demonstrated that Aifukang capsules improve immune function of patients, increase body weight, and alleviate clinical symptoms such as fatigue, decreased appetite, and headache. This suggests that Aifukang capsules contain components that enhance immune system function and alleviate symptoms.

Aifukang capsules have shown a series of positive therapeutic effects in HIV/AIDS treatment. According to Mao et al. (108) and Mao (109), Aifukang capsules improved immune indicators and reduced the viral load in patients with HIV/AIDS with hot toxins and internal accumulation while alleviating the toxic side effects of HAART (110). However, owing to the differences between various studies, further clinical and basic research is needed to validate its efficacy and safety. In summary, the application prospects of Aifukang capsules in HIV/AIDS treatment remain promising, offering novel insights and approaches for the development of the field.

3.7 Fuzheng Kang'ai formula

The Fuzheng Kang'ai Formula is composed of various traditional Chinese herbs, including A. membranaceus, Codonopsis pilosula, Curcuma longa, and G. uralensis. This formula strictly adheres to the treatment principle of “strengthening the body's foundation to eliminate the root cause while dispelling pathogenic factors to address the symptoms.” It combines TCM knowledge with modern pharmacological research to create well-balanced formulations. This formula balances nourishment and purging with cold and warm properties, promotes blood circulation to dispel toxins, and clears blockages to help the body resist and expel pathogens (111). It is suitable for patients with AIDS exhibiting symptoms of “Qi deficiency and blood stasis.”

Liu (112) showed that Fuzheng Kang'ai Formula significantly improved patient symptoms and signs, increased CD4 cell levels, inhibited and stabilized viral replication, and had some inhibitory effects on CCR5 and CXCR4 expression. Additionally, the formula effectively alleviated symptoms such as fatigue, poor appetite, hair loss, abdominal distension, and muscle pain in patients with AIDS diagnosed with the TCM pattern of “Qi deficiency and blood stasis” (113). Liu (163) further confirmed that the formula could enhance cellular immune function in mice and block HIV infection through competitive binding with CCR5. These findings suggest that the Fuzheng Kang'ai Formula contains components that enhance immune function, promote blood circulation to eliminate toxins, and inhibit viral replication.

The Fuzheng Kang'ai Formula has shown significant therapeutic effects in clinical studies. Multiple studies have shown that this formula enhances immune function, alleviates clinical symptoms, stabilizes viral load, and slows disease progression. Wang (111) demonstrated that the Fuzheng Kang'ai Formula increased the secretion of IL-2 and IFN-γ, elevated T cell counts and enhanced immune function. The Fuzheng Kang'ai Formula demonstrated enhanced treatment effects when used in conjunction with antiretroviral drugs (HAART). The effect of the formula on T cell surface PD-1 expression and CD8+ T lymphocyte count varies among different studies. Some studies have also explored the mechanism of action of the Fuzheng Kang'ai Formula, such as its regulation of phospholipid transport and its effects on the TLR4 receptor. Clinical observations have shown that the Fuzheng Kang'ai Formula is safe for treating patients with HIV/AIDS, which synergistically enhances immune reconstruction and improves quality of life, especially when used in combination with HAART.

3.8 Taiqi Peiyuan granules

Taiqi Peiyuan granules are a TCM compound preparation composed of various Chinese herbs. The major ingredients include A. membranaceus, C. pilosula, C. longa, Rehmannia glutinosa, Ophiopogon japonicus, and G. uralensis. These herbs are primarily used for patients with HIV/AIDS who exhibit deficiencies in both Qi and Yin and lung and kidney deficiencies. Multiple clinical observational studies have shown that Taiqi Peiyuan granules improve immune function (114, 115, 121), increase CD4+ T lymphocyte counts (114–116, 118), raise the CD4+/CD8+ ratio, enhance immune function, control virus replication (114–116), and maintain the health of patients (114–117, 120–122, 164). The formula also has a positive impact on clinical symptoms in patients with HIV/AIDS, presenting with symptoms such as insomnia, restlessness, night sweats, spontaneous sweating, fatigue, susceptibility to cold, and phlegm production (116). Taiqi Peiyuan granules influence the expression of PD-1 on T cell surfaces, affecting T cell activation (115). The formula assists in reducing the viral load when used in combination with antiretroviral drugs, possibly owing to its regulation of immune cell function (116). Clinical observations have indicated that Taiqi Peiyuan granules are safe for the treatment of HIV/AIDS, particularly when used in conjunction with HAART, as this combination can synergistically enhance immune reconstitution and improve quality of life of patients (114, 115, 117–119, 121).

3.9 Immunity 1

Immunity 1 primarily consists of ingredients such as western ginseng, Cordyceps sinensis, and Isodon amethystoides. It is a TCM compound granule developed based on the mechanism of HIV/AIDS through long-term clinical practice for the prevention and treatment of AIDS, with efficacy in strengthening the body and providing detoxification. Immunity 1 effectively improved immune function in patients with latent HIV/AIDS. According to research findings, immunity 1 mainly acts on the elevation of CD45RO; however, after 6 months of treatment, it mainly acts on CD45RA (123). Combining Immunity 1 with antiretroviral therapy (HAART) significantly promoted immune reconstitution in patients with HIV/AIDS. Immunity 1 treatment effectively improves symptoms and signs in patients with HIV/AIDS, particularly digestive system symptoms, such as poor appetite and diarrhea (124). As a TCM prescription, Immunity 1 exhibits a significant immune regulatory effect in the treatment of patients with AIDS. By promoting improved immune function, Immunity 1 helps to elevate the level of immune reconstitution in patients, especially those with HIV/AIDS.

3.10 Immunity 2

Immunity 2 is a TCM compound prescription that mainly includes Western ginseng, C. sinensis mycelia, and Schisandra chinensis, among other ingredients. By adhering to the principles of tonifying the body and eliminating pathogenic factors while clearing heat and detoxifying, Immunity 2 aims to strengthen the body's foundation, resist pathogenic factors, promote immune reconstitution, and either suppress disease progression or maintain a balance between health and disease in patients with AIDS. Immunity 2 increases the absolute count of CD4 cells in patients, promotes immune reconstitution, and effectively improves immune function (125, 129). Treatment with Immunity 2 significantly improves symptoms such as fatigue, joint and muscle pain, skin itching, and shortness of breath, and enhances the quality of life (126, 165). Studies have indicated that Immunity 2 can partially restore CD45RA and CD45RO cell subpopulations (129). Additionally, when treating patients with HIV/AIDS with immune reconstitution deficiency, Immunity 2 affects the TLR9-mediated signaling pathway, which may be one of the mechanisms for improving abnormal immune activation (165). Immunity 2 treatment can increase the CD4 lymphocyte count in patients with immune reconstitution deficiency, thereby enhancing the body's immune response (127). Immunity 2 demonstrates significant therapeutic effects in patients with immune reconstitution deficiency. Through immune function regulation and the promotion of increased CD4 cell counts, this prescription effectively improves clinical symptoms, enhances quality of life, and helps restore abnormal immune states.

3.11 Other traditional Chinese medicine compound formulations

Several clinical trials have shown that various other TCM preparations had positive effects on the immune function and clinical symptom improvement of patients with HIV/AIDS (130, 132, 156). These TCM formulations help in increasing CD4+ T lymphocyte counts, reducing the viral load, improving immune function, alleviating clinical symptoms, and ultimately enhancing the quality of life of patients. For example, Qian Kun Ning, Zhen Qi Fu Zheng capsules, and compound Astragalus granules have been shown to significantly increase CD4+ T cell counts, thereby enhancing immune function (132, 133, 138, 148, 150). In addition, Xiao Yao San He Er Chen Tang, Wen Bu Pi Shen Fang, Pu Le Kang Oral Liquid, and other TCM formulations have been effective in inhibiting virus replication, reducing viral load, improving clinical symptoms, and significantly enhancing quality of life of patients (130, 133, 137, 139, 140, 154). Additionally, improvements in clinical symptoms, such as increased body weight and reduced fatigue, have been observed with the use of these formulations (137, 142, 151). However, discrepancies were there in the results, with some studies not observing significant therapeutic effects (135, 150), which may be attributed to factors such as the specific formulation and the study population. Safety assessment is another crucial aspect of these studies, with most indicating that TCM formulations are safe for treatment with no apparent adverse reactions or toxic side effects (133, 152, 154). However, some studies reported potential side effects that require further verification (146, 153). This underscores the importance of a high level of safety in TCM treatment.

Nonetheless, different TCM formulations exhibit differences in their treatment efficacy and mechanisms. Clinical observational data indicate that the efficacies and mechanisms of action of various TCM formulations are not identical. For example, Qian Kun Ning primarily improves patients' blood lipid levels and clinical symptoms by alleviating symptoms related to liver depression, spleen deficiency, and phlegm stagnation (131). Conversely, Qian Kun Ning effectively reduces mortality and plasma viral load and increases CD4+ T cell counts in patients with HIV/AIDS (132). Zhen Qi Fu Zheng capsules, when used in combination with HAART, increase neutrophil and CD4+ T lymphocyte counts, improve quality of life, and reduce adverse reactions to HAART drugs (133). Therefore, while TCM treatment shows positive effects in most cases, decisions regarding treatment options should consider the specific circumstances of the patients and be supported by data from clinical trials.

4 Pharmacological experimental results of traditional Chinese medicine compound formulations

Compound herbal formulations have been extensively examined through in vitro and in vivo animal studies to understand their mechanisms of action against HIV. These studies investigated their impact on aspects such as viral replication, viral invasion of host cells, and immune regulation. Various active ingredients within compound formulations may exert their effects through different pathways, including the inhibition of HIV viral replication enzymes, anti-inflammatory actions, and modulation of cytokine production. Some pharmacological experiments have shown that compound formulations inhibit HIV replication, reduce viral load, and modulate the immune system (166). Additionally, some compound formulations promote the growth and functional recovery of CD4+ T lymphocytes (162, 163). Qian et al. (158) and Zeng et al. (164) found that Yi Ai Kang Capsules and Taiqi Peiyuan granules, respectively, inhibited NK cell apoptosis and regulated the immune function of immunocompromised mice by increasing NK cell numbers (158, 164). Yi Ai Kang Capsule belong to one kind of TCM which is composed of various herbs, including Ginseng, Astragalus membranaceus, Saposhnikovia divaricate, and others, with the function of alleviating the symptoms of AIDS opportunistic infection. Yi Ai Kang Capsules have been demonstrated to lower the permeability of the intestinal mucosal barrier damaged by HIV, reduce cell apoptosis rates, and maintain the integrity of the intestinal mucosal barrier (167–169). Yi Ai Kang Capsules can alleviate lopinavir-induced lipid metabolism disorders, promote the uptake and transport of fatty acids, and enhance lipid clearance, thereby exerting a lipid-lowering effect (168). Fuzheng Paidu tablet includes Western ginseng, Astragalus membranaceus, Forsythia suspensa and other traditional Chinese herbs. Fuzheng Paidu tablet regulates the immune function of immunosuppressed mice, primarily by promoting lymphocyte transformation and enhancing the formation of hemolysins and hemolysis plaques (161, 162).

5 Compound herbal formulations combined with HAART treatment: a novel therapeutic strategy

In clinical studies, TCM preparations are frequently used as adjunctive therapies, often combined with HAART, to improve treatment outcomes. Different TCM preparations have demonstrated diverse synergistic effects when used in combination with HAART. For example, Zhen Qi Fu Zheng Capsules, one kind of oral TCM, mainly include Astragalus membranaceus and Ligustrum lucidum. Zhen Qi Fu Zheng Capsules combined with HAART reduce the adverse effects of HAART drugs and increase CD4+ T lymphocyte counts, and they have no significant impact on HIV viral load conversion rates (133). Similarly, when combined with HAART, Wen Bu Pi Shen Fang and Wen Shen Jian Pi Fang promote immune reconstitution in HAART non-responders, improve the distribution of NK cell subpopulations, and enhance patient quality of life (140, 141). This suggests that using TCM in conjunction with HAART will further enhance treatment effectiveness, improve immune function, and reduce treatment-related adverse reactions.

In clinical settings, compound herbal formulations are typically used in conjunction with modern antiretroviral therapy (HAART) to achieve better treatment outcomes. The role of herbal formulations in this combined treatment approach may involve several factors such as:

1. Synergistic viral suppression: Compound herbal formulations with HAART drugs synergistically inhibit viral replication via different pathways, thereby enhancing the effectiveness of viral replication inhibition.

2. Immune function restoration: Compound herbal formulations may help repair the damaged immune systems of patients with HIV/AIDS through immune modulation, increasing the body's natural defense mechanisms and strengthening its ability to combat the virus.

3. Mitigation of side effects: Some components within compound herbal formulations may possess anti-inflammatory and antioxidant properties, potentially helping to alleviate the side effects of HAART drugs and improve quality of life of patients.

The role of herbal formulations is characteristic by combining compound with HAART should be performed under the guidance of a medical professional, with dosages and treatment plans adjusted according to the specific circumstances of each patient. Further clinical trials and in-depth studies are needed to validate the safety and efficacy of this combined treatment strategy.

6 Conclusion and outlook

6.1 Advantage of the effects of TCM on HIV/AIDS treatment

Human immunodeficiency virus and AIDS are major global health problems. Despite significant advances in modern antiretroviral therapy (ART), issues related to long-term side effects, drug resistance, and other challenges persist. Herbal medicines have garnered significant attention from scientists as a potential adjunctive treatment. This study aimed to explore the role of herbal medicines in treating HIV/AIDS.

The role of herbs in HIV/AIDS treatment extends beyond direct antiviral activity; it also includes the modulation of the host immune system. Certain herbs enhance immune function and reduce immune suppression, thereby reducing the risks of infection and disease progression. Additionally, some TCM possess anti-inflammatory, antioxidant, and antifibrotic properties, which reduce the side effects of ART and improve the overall quality of life.

6.2 Limitation of TCM in HIV/AIDS treatment

Although herbal medicines have therapeutic potential in HIV/AIDS treatment, many unknown areas require further research. First, a deeper understanding of the specific antiviral mechanisms of herbs is required, including their effects at different stages of the viral life cycle. Current studies showed that several herbal medicine, such as Golobe Halmahera, Pangium edule Reinw, and Love herbal (LH) medicine, have significant antiviral effects (170–172). The components of these herbal medicine have the potential to be developed into chemotherapeutic drugs, especially with the clear acquisition of some of their structures, which allows for in-depth functional research. Therefore, to explore the structures of chemical compositions of TCM mentioned in this review is also a focus of future research.

Second, rational combinations of herbs enhance their therapeutic effects, and the synergistic interactions between herbal medicines require further exploration. Furthermore, optimizing the dosage forms of herbal preparations is crucial for ensuring the stability and bioavailability of active ingredients.

6.3 Future work on TCM in HIV/AIDS treatment T

In summary, herbal medicines show promise for the treatment of HIV/AIDS. In addition to directly inhibiting viral activity, they also regulate immune function and reduce adverse reactions. However, the therapeutic effects of TCM need further research and validation. Future studies should focus on the antiviral mechanisms of herbs, rational combinations, and dosage form optimization. In clinical applications, to ensure the best treatment outcomes for patients, caution should be exercised, and the guidance of modern medicine should be considered. Herbal medicine holds vast potential as an adjunctive treatment for HIV/AIDS and is expected to provide more treatment options and improve the quality of life of patients with HIV/AIDS. Therefore, clarifying the efficacy and mechanisms of TCM in treating HIV/AIDS and improving diagnosis and treatment system for AIDS would be the future research theme.

Author contributions

NZ: Funding acquisition, Investigation, Writing – original draft. MW: Formal analysis, Validation, Writing – original draft. LG: Investigation, Supervision, Writing – original draft. CZ: Investigation, Writing – original draft. XT: Investigation, Writing – original draft. XL: Investigation, Supervision, Validation, Writing – review & editing. CB: Investigation, Supervision, Validation, Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Project of the Department of Science and Technology of Inner Mongolia Autonomous Region (2020BS03021), the Project of the Department of Science and Technology of Jilin Province, China (No. 20220202076NC), the Project of Natural Science Research of Chifeng City (No. SZR24001), the Project of the second batch of PHDS of Chifeng College (No. 2024FWDF10), and the National College Students' Innovation and Entrepreneurship Training Program (No. S202410138020).

Acknowledgments

We would like to thank the Editage team for English language editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2024.1322870/full#supplementary-material

Supplementary Table 1. Scientific names matching literary names of each TCM were displayed.

References

1. Prendergast AJ, Essajee S, Penazzato M, HIV. and the Millennium Development Goals. Arch Dis Child. (2015) 100:S48–52. doi: 10.1136/archdischild-2013-305548

PubMed Abstract | Crossref Full Text | Google Scholar

2. Moss JA. HIV/AIDS review. Radiol Technol. (2013) 84:247–70.

Google Scholar

3. Global HIV & AIDS statistics — Fact sheet. Available online at: https://www.unaids.org/en/resources/fact-sheet

Google Scholar

4. Okoye AA, Picker LJ. CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev. (2013) 254:54–64. doi: 10.1111/imr.12066

PubMed Abstract | Crossref Full Text | Google Scholar

5. Palmer CD, Ninkovi J, Prokopowicz ZM. The effect of stable macromolecular complexes of ionic polyphosphazene on HIV Gag antigen and on activation of human dendritic cells and presentation to T-cells. Biomaterials. (2014) 35:8876–86. doi: 10.1016/j.biomaterials.2014.06.043

PubMed Abstract | Crossref Full Text | Google Scholar

6. Pu JY, He L, Wu SY. Anti-virus research of tritezarpenoids in licorice. Bing Du Xue Bao. (2013) 29:673–9.

Google Scholar

7. Zhang YL. Exploration of the theoretical basis and methods of Chinese medicine in the treatment of AIDS. Tian Jin Zhong Yi. (1994) 11:46–8.

PubMed Abstract | Google Scholar

8. Harada S. The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope. Biochem J. (2005) 392:191–9. doi: 10.1042/BJ20051069

PubMed Abstract | Crossref Full Text | Google Scholar

9. Sasaki H, Takei M, Kobayashi M. Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients. Pathobiology. (2002) 70:229–36. doi: 10.1159/000069334

PubMed Abstract | Crossref Full Text | Google Scholar

10. He J. The Effects and mechanism of glycyrrhizin on rat myocardium injury induced by R5 type HIV-1gp120. Fujian Medical University (2019). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRD720zlIgm6BbTvhP7XL7SvNgOQYZC9_1v6wS2uyvLl1AY5peSy93rPMEWU9YBOw51_hAQp4aK1AfaAr9_1_yOCDc9KeNPSKy4M6qqeqQYKM63WJUDDFO2MOVb2iwXWYT0=&uniplatform=NZKPT&flag=copy (accessed July 31, 2024).

Google Scholar

11. Hatano T, Yasuhara T, Miyamoto K, Okuda T. Anti-human immunodeficiency virus phenolics from licorice. Chem Pharm Bull. (1988) 36:2286–8. doi: 10.1248/cpb.36.2286

PubMed Abstract | Crossref Full Text | Google Scholar

12. Wang YW, Zhang HB, Shi YR. Inhibition of clycyrrhize polysaccharide on virus. Acta Scient Natur Univ Nankaiensis. (2001) 34:126–8.

Google Scholar

13. Kashiwada Y, Nishizawa M, Yamagishi T. Anti-AIDS agents, 18. Sodium and potassium salts of caffeic acid tetramers from Arnebia euchroma as anti-HIV agents. J Nat Prod. (1995) 58:392–400. doi: 10.1021/np50117a007

PubMed Abstract | Crossref Full Text | Google Scholar

14. Chen X, Yang L, Zhang N. Shikonin, a component of Chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother. (2003) 47:2810–6. doi: 10.1128/AAC.47.9.2810-2816.2003

PubMed Abstract | Crossref Full Text | Google Scholar

15. Maierdan M, He JH, Gulixian H. Study on anti-HIV-1 activity of extracts from Arnebia Euchroma (Royle) Johnst in vitro. J Xinjiang Med Univ. (2009) 32:374–7.

Google Scholar

16. Maierdan M, Gulixian H, Qin DM. Activity of extracts from Arnebia Euchroma (Royle) Johnst to HIV-1key enzymes in vitro. J Xinjiang Med Univ. (2009) 32:377–9.

Google Scholar

17. Li Q, Chen HY, Lian YJ. Effects of polysaccharides from Arnebia euchroma on immune functions of mice. Chin J Hosp Pharm. (2011) 31:829–32.

Google Scholar

18. Chang RS, Yeung HW. Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs. Antiviral Res. (1988) 9:163–75. doi: 10.1016/0166-3542(88)90001-0

PubMed Abstract | Crossref Full Text | Google Scholar

19. Ngan F, Chang RS, Tabba HD, Smith KM. Isolation, purification and partial characterization of an active anti-HIV compound from the Chinese medicinal herb viola yedoensis. Antiviral Res. (1988) 10:107–16. doi: 10.1016/0166-3542(88)90019-8

PubMed Abstract | Crossref Full Text | Google Scholar

20. Wang CK, Colgrave ML, Gustafson KR. Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis. J Nat Prod. (2008) 71:47–52. doi: 10.1021/np070393g

PubMed Abstract | Crossref Full Text | Google Scholar

21. Chang CW, Lin MT, Lee SS. Differential inhibition of reverse transcriptase and cellular DNA polymerase-alpha activities by lignans isolated from Chinese herbs, Phyllanthus myrtifolius Moon, and tannins from Lonicera japonica Thunb and Castanopsis hystrix. Antiviral Res. (1995) 27:367–74. doi: 10.1016/0166-3542(95)00020-M

PubMed Abstract | Crossref Full Text | Google Scholar

22. Ma SC Bi PX, Huang RC. Determination of the Antiviral Caffeoyl Quinic AcidsIsolated from Lonicera japonica Thunb. Chin J Pharm Anal. (2005) 25:751–5.

Google Scholar

23. Li N, Li F. Progress in the study of antiviral effects of Astragalus membranaceus. Shandong J Tradit Chin Med. (2015) 34:566–8.

Google Scholar

24. Xiong M, Zhang YJ, Xu SJ. Research progress on anti-virus effects of Astragali Radix. Phar Clin Chin Mater Med. (2012) 3:50–3.

Google Scholar

25. Wu CH. Studies on the Inhibitory effects of Astragalus extracts on HIV-1 and the Possible Mechan. Tianjin University (2020).

Google Scholar

26. Xu S, Wang L, Yang QF. Antiviral effect and mechanism of scutellaria baicalensis Georgi. Chinese Arch Tradit Chin Med. (2007) 25:1355–7.

Google Scholar

27. Chen DG. Interaction between HIV-1 integrase and baicalein studied by molecular modelling techniques. Guide China Med. (2009) 7:157–9.

Google Scholar

28. Wang XH, Yan CY Yu GY. Research Progress and Clinical Application of Scutellaria Baicalensis Against Viral Infection. Pharmacy Today. (2021) 31:874–80.

PubMed Abstract | Google Scholar

29. Ono K, Nakane H, Fukushima M. Inhibition of reverse transcriptase activity by a flavonoid compound, 5,6,7-trihydroxyflavone. Biochem Biophys Res Commun. (1989) 160:982–7. doi: 10.1016/S0006-291X(89)80097-X

PubMed Abstract | Crossref Full Text | Google Scholar

30. Chen HS. Xiao Chai Hu Tang and its constituents Antagonistic effect of Huang Cen extract. Infect Dis Inf . (1995) 8:21.

Google Scholar

31. Li BQ, Fu T, Yan YD. Inhibition of HIV infection by baicalin–a flavonoid compound purified from Chinese herbal medicine. Cell Mol Biol Res. (1993) 39:119–24.

PubMed Abstract | Google Scholar

32. Kitamura K, Honda M, Yoshizaki H. Baicalin, an inhibitor of HIV-1 production in vitro. Antiviral Res. (1998) 37:131–40. doi: 10.1016/S0166-3542(97)00069-7

PubMed Abstract | Crossref Full Text | Google Scholar

33. Li BQ, Fu T, Dongyan Y. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Biophys Res Commun. (2000) 276:534–8. doi: 10.1006/bbrc.2000.3485

PubMed Abstract | Crossref Full Text | Google Scholar

34. Wang Q, Wang YT, Pu SP. Zinc coupling potentiates anti-HIV-1 activity of baicalin. Biochem Biophys Res Commun. (2004) 324:605–10. doi: 10.1016/j.bbrc.2004.09.093

PubMed Abstract | Crossref Full Text | Google Scholar

35. Sun Z, Ma Z, Zhang W. Electrochemical investigations of baicalin and DNA-baicalin interactions. Anal Bioanal Chem. (2004) 379:283–6. doi: 10.1007/s00216-004-2542-0

PubMed Abstract | Crossref Full Text | Google Scholar

36. Chen HS, Yan XG, Zhang XQ. Studies on the in vitro and in vivo anti-AIDS and hepatitis B virus effects of the Chinese medicine Salvia miltiorrhiza (Briefing). Chin Acad Med Sci. (1996) 6:481.

Google Scholar

37. Zhao SJ, Zhang GY, Liu D. Advances in research of pharmacological activities and biosynthesis pathway of water-soluble phenolic compounds of Salvia miltiorrhiza. Chin Tradit Herbal Drugs. (2004) 35:341–4.

Google Scholar

38. Abd-Elazem IS, Chen HS, Bates RB. Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza. Antiviral Res. (2002) 55:91–106. doi: 10.1016/S0166-3542(02)00011-6

PubMed Abstract | Crossref Full Text | Google Scholar

39. Qin DH, Chen HS, Peng ZG. A new compound from Salvia przewalskii and its anti-HIV effect. Chin Tradit Herbal Drugs. (2004) 35:725–8.

Google Scholar

40. Zhang ZF, Peng ZG, Gao L. Three new derivatives of anti-HIV-1 polyphenols isolated from Salvia yunnanensis. J Asian Nat Prod Res. (2008) 10:391–6. doi: 10.1080/10286020801966591

PubMed Abstract | Crossref Full Text | Google Scholar

41. Mori M, Ciaco S, Mély Y, Karioti A. Inhibitory effect of lithospermic acid on the HIV-1 nucleocapsid protein. Molecules. (2020) 25:5434. doi: 10.3390/molecules25225434

PubMed Abstract | Crossref Full Text | Google Scholar

42. He ZX, Yan F, Shi YY. Progress on the pharmacological effects of Andrographis paniculate. Modern Agric Sci Technol. (2009) (3):21–5.

Google Scholar

43. Chang RS, Ding L, Chen GQ. Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus. Proc Soc Exp Biol Med. (1991) 197:59–66. doi: 10.3181/00379727-197-43225

PubMed Abstract | Crossref Full Text | Google Scholar

44. Ma YY, Li M, Ma J. Effect and mechanism of Andrographitis Herba on human CD4 +T cell Promoters CXCR4 and CCR5. China J Chin Mater Med. (2011) 36:3012–7.

Google Scholar

45. Uttekar MM, Das T, Pawar RS. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding. Eur J Med Chem. (2012) 56:368–74. doi: 10.1016/j.ejmech.2012.07.030

PubMed Abstract | Crossref Full Text | Google Scholar

46. Zhang XY, Yang CQ. Chemical composition and pharmacological effects of Ganoderma lucidum. World Notes on Antibiotics. (2006) 21:152–5.

Google Scholar

47. Liu J. Antivirial and Antitumor Activities of Polysaccharides Isolated from Mycelia of Ganoderma lulidum. Wuhan University (2005). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRALWYXH8tFp0s7dBtTlB6cfQyGJpUQ46tAPJOEbjc3KpQlTScGS2P8vtEHm9_VEZWfPSlHjZQHpUmVW377Y-wHPXX7XREmMHD2v4FEEnbjVZ79iDi3QU8xB&uniplatform=NZKPT&flag=copy

PubMed Abstract | Google Scholar

48. Kim HW, Shim MJ, Choi EC, Kim BK. Inhibition of cytopathic effect of human immunodeficiency virus-1 by water-soluble extract ofGanoderma lucidum. Arch Pharm Res. (1997) 20:425–31. doi: 10.1007/BF02973934

PubMed Abstract | Crossref Full Text | Google Scholar

49. El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N, et al. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry. (1998) 49:1651–7. doi: 10.1016/S0031-9422(98)00254-4

PubMed Abstract | Crossref Full Text | Google Scholar

50. Min BS, Nakamura N, Miyashiro H, Bae KW, Hattori M. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull. (1998) 46:1607–12. doi: 10.1248/cpb.46.1607

PubMed Abstract | Crossref Full Text | Google Scholar

51. Devinna K, Mutakin M, Jutti L. Computational study of triterpenoids of ganoderma lucidum with aspartic protease enzymes for discovering HIV-1 and plasmepsin inhibitors. Int J Chem. (2015) 7:62–8. doi: 10.5539/ijc.v7n1p62

Crossref Full Text | Google Scholar

52. Cheng PG, Teoh TC, Rizman-Idid M. Chemical compounds and computational prediction of their inhibitory effects on the HIV-1 gp120 receptor by Lingzhi or Reishi medicinal mushroom, ganoderma lucidum (agaricomycetes), with antler-like morphology of fruiting bodies. Int J Med Mushrooms. (2021) 23:63–77. doi: 10.1615/IntJMedMushrooms.2021038682

PubMed Abstract | Crossref Full Text | Google Scholar

53. Schinazi RF, Chu CK, Babu JR. Anthraquinones as a new class of antiviral agents against human immunodeficiency virus. Antiviral Res. (1990) 13:265–72. doi: 10.1016/0166-3542(90)90071-E

PubMed Abstract | Crossref Full Text | Google Scholar

54. Jiang Y. In vitro experimental studies on the anti-HIV-1 activity of Cynodon grandiflorus (Cynodon grandiflorus). Foreign Med Sci: Tradit Chin Med. (1994) 68:282.

Google Scholar

55. Jiang Y, Wang HX, Bao ZY. Evaluation of antiviral effect of Polygonum cuspidatum water extract with a model of murine acquired immunodeficiency syndrome. Virol Sin. (1998) 13:306–11.

Google Scholar

56. Lin HW, Sun MX, Wang YH. Anti-HIV activities of the compounds isolated from Polygonum cuspidatum and Polygonum multiflorum. Planta Med. (2010) 76:889–92. doi: 10.1055/s-0029-1240796

PubMed Abstract | Crossref Full Text | Google Scholar

57. Yao XJ, Wainberg MA, Parniak MA. Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris. Virology. (1992) 187:56–62. doi: 10.1016/0042-6822(92)90294-Y

PubMed Abstract | Crossref Full Text | Google Scholar

58. Kageyama S, Kurokawa M, Shiraki K. Extract of Prunella vulgaris spikes inhibits HIV replication at reverse transcription in vitro and can be absorbed from intestine in vivo. Antivir Chem Chemother. (2000) 11:157–64. doi: 10.1177/095632020001100207

PubMed Abstract | Crossref Full Text | Google Scholar

59. Liu S, Jiang S, Wu Z. Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte. Life Sci. (2002) 71:1779–91. doi: 10.1016/S0024-3205(02)01939-2

PubMed Abstract | Crossref Full Text | Google Scholar

60. Zhang R. Clinical study on the effect of Spica Prunellae polysaccharide on inducing PBMC cytokines and cell apoptosis of HIV-1 infected individuals. J Henan Univ Chin Med. (2015) (1):9–10.

Google Scholar

61. Oh C, Price J, Brindley MA. Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L. Virol J. (2011) 8:1–10. doi: 10.1186/1743-422X-8-188

PubMed Abstract | Crossref Full Text | Google Scholar

62. Li FZ, Xu LR, Zhang ML. Clinical observation on 885 AIDS patients treated by yiaikang capsule combined with treatment based on syndrome differentiation. J Tradit Chin Med. (2010) 51:808–10.

Google Scholar

63. Henan Provincial Clinical Expert Group on Tradit Chin Med for the Treatment of A. Intervention of Yi Aikang Capsules in 379 HIV-infected patients with asymptomatic stage of HIV infection. TCM Res March. (2008) 21:31–3.

Google Scholar

64. Yang CL. Clinical study on reducing the incidence of AIDS pulmonary infection with Tradit Chin Med. Henan University of Chinese Medicine (2022). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRAnhpotaf8hn7Dr14HTDUH5IWWe8cFmPoMAJK96vtOh_2X_JgAneaaVjkeucMr8F8qNP2r7hA0DmJKiFivoLp4NF64qbE6xExaafZD37l9gQ642IVNBluFp&uniplatform=NZKPT&flag=copy (accessed July 31, 2024).

Google Scholar

65. Zhang ZK. Mechanism of Yiaikang capsule in the treatment of AlDS basedon ID2/E2A signal axis and PD- signal pathway. Henan University of Chinese Medicine (2022). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRAlcXPSP0bQUodV_KaERU7Wt7fbX-5ZUavt-VEkL1Cm4lSuTCW8cuNZpn_1ZQMW7VS5YKSvV0oPzKNR826az2wgefiveCa7BSwLkIt6h-9MwNhVYP_1BEKC&uniplatform=NZKPT&flag=copy (accessed July 31, 2024).

Google Scholar

66. Wang YY. Clinical Observation of Yiaikang Capsule in the Treatment of HIV/AIDS Immune Reconstruction Syndrome of Bad. China Academic Journal Electronic Publishing House (2022) 62.

Google Scholar

67. Liu YN, Liu ZB, Sang F. Effects of Yiaikang capsules on intestinal microflora and immune function in Hiv/Aids patients with poor immune reconstitution of lung and spleen qi deficiency syndrome. China J Tradit Chin Med and Pharmacy. (2022) 37:2729–33.

Google Scholar

68. Li R, Liu Z, Li Q. Effects of Yiaikang treatment on CCR5, CXCR4 expression and T cell activation in HIV-1 infected patients. J Basic Chinese Medicine. (2018) 24:1424–57.

Google Scholar

69. Xu ZJ. To Observe the Clinical Curative Effect of Yiaikang Capsule in the Treatment of Hiv/Aids Lung Spleen Qi Deficiency and of Nf-κb Signaling Pathway. Henan University of Chinese Medicine (2018). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRDJt8IcDf1jLlpoTr6oLwCXOdTa6F4aKErT-UT4NMVSmTkqij-7b0DIVNt8KE1WCRueTwcEvBx_rrdKQvAIOwWHYj7Z9XEI8Z1wRQv69Cns866Bph2mLHW5D1K15oSDSZ4=&uniplatform=NZKPT&flag=copy (accessed July 31, 2024).

Google Scholar

70. Zhang H, Xu ZJ, Hua CC, Yi. Aikang Capsule combine with zhike powder in treating cough in 48 cases with AIDS. Clinical J Tradit Chin Med. (2017) 29:1890–2.

Google Scholar

71. Li P. The long-term Clinical Effect Analysis of BOTA FOR AID Capsule on Prevention and Treatment for HIV cases. Guangzhou University of Chinese Medicine (2010). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRDIiCqAhpiAEB9wkG842855650LuGgpdJR4iHFE_sKhf4TLSLYFnmVDZT21yHoXRjHipsTYBRfSkK-KbenrBEV3rIHLRmNTfxGCnxhaTQW58TGkRUrGpRYQ&uniplatform=NZKPT&flag=copy (accessed July 31, 2024).

Google Scholar

72. Zuo XT. A sixty-month study on retrospective analysis of Aikeqing Capsule in treating HIV/AIDS patients. Guangzhou University of Chinese Medicine (2017). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRD8sN6bHB8S4hTJMaSr7MQXWyIc7cN3UgvhTmpF-JRFqL0uKIQCOZv5Po6DmTuDRmxyv-Xn47t0yChe182-IMLyT-15mhZEnJ33z3qD28G-nboUj5l_w5ZGa036mK-JBn8=&uniplatform=NZKPT&flag=copy (accessed July 31, 2024).

Google Scholar

73. Cao TZ. 30 Cases of Clinical Observation of Tradition Chinese Medicine compound Capsule “Ai keqing” united HAART for AIDS Treatment. Hbtcm. (2009) 35.

Google Scholar

74. Dong JP, Wang J, Xu LR. Clinical study on HAART adverse reaction in 536 HIV/AIDS patients treated with Chinese herbs. CJTCMP. (2017) 32:870–4.

Google Scholar

75. Wang XY. Investigate of Aikeqing on inflammation after HAART based on ADAM17. Guangzhou University of Chinese Medicine (2018). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C447WN1SO36whLpCgh0R0Z-iDdIt-WSAdV5IJ_Uy2HKRAZ8LKiFGLaKsLEj_gfiSYv3NgOdfec-uz79xVi2sqF0z&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

76. Wang DN. Effect of Fuzheng Paidu Tablet in Regulating Immune Function of Asymptomatic HIV Carriers. NanJing University of Chinese Medicine (2011). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRB9JDHRnWE3iG1gnWDklCyGBJN5SEIMS5n6wTdDtGLO7a7zz1bD83Zm3LU5yOTdvZw_BfcLPH0DcnSyKNCmPGeqCGUYmS1EYrH0ZPDqwjLerI05z0XH2EPw&uniplatform=NZKPT&flag=copy (accessed July 31, 2024).

Google Scholar

77. Peng B, Wang DN. Clinical observation on 65 cases of HIV asymptomatic carriers treated by FuzhengPaidu Tablet II. Chin Arch Tradit Chin Med. (2006) 24:1781–3.

Google Scholar

78. Liu XW. Clinical Research on Earlier Period Intervention of Fuzheng Paidu Tablet to HIV Asymptomatic Carrier. Henan University of Chinese Medicine (2007).

Google Scholar

79. Tan LX. Research on the intervention effect of Fuzheng anti-toxic capsule on the concurrent infection of HIV/HCV. YunNan University of Chinese Traditional Medicine (2016). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRCG79T8GxkHM8i7uGm2PCOOhV6Fitabd9HOfF8M_b5RLXEsC8Hq-2cQywEwKNBk-ZIojTjzPlS7EVjPTeOszNuJj0LdTmeLEvEYUefBTbrvVE5bdwXUBEiUw_Ka9xP1QHo=&uniplatform=NZKPT&flag=copy (accessed July 31, 2024).

Google Scholar

80. Jiang F, Gu ZF, Li ZW. Effect of Fuzheng detoxification tablets on interferon alpha in asymptomatic human immunodeficiency virus-infected patients. CJITWM. (2012) 32:1700–1.

Google Scholar

81. Liu J. Long-term clinical study of Ailing granules synergising with HAART in the treatment of AIDS patients with qi deficiency and blood investigation type. China Academy of Chinese Medical Sciences (2005). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAk6at-NE8M3PgrTsq96O6n6VTDmUnXXEKyGOgulpZuY4vEIfPMaMvUsE7roAR_lxie&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

82. Wei JA, Liu J, Song CX. Clinical summarization of patients living with treatment of ailing granule. J Henan Univ Chin Med. (2008) 23:6–7.

Google Scholar

83. Wei JA, Liu J, Wang FS. Effect of Ailing granule on peripheral dendritic cell subsets inindividuals infected with HIV. Chin J AIDS STD. (2008) 14:235–7.

Google Scholar

84. Wei JA, Jin Y, Chen YX. A report of clinical observation of 19 HIV/AIDS cases treated with a traditional drug named AiLing. Chin J AIDS STD. (2006) 12:105–7.

Google Scholar

85. Wei JA, Song CX Li N. Clinical observation on 15 cases of HIV-infected patients treated with Ailing granules. Beijing J Tradit Chin Med. (2011) 30:483–5.

Google Scholar

86. Wei JA, Sun LM, Chen YX. Clinical study of Ailin granule in treating 104 cases of HIV/AIDS. J Henan Univ Chin Med. (2006) 21:4–6.

Google Scholar

87. Wei JA, Sun LM, Chen YX. Effects of Ailing granule on immuno-reconstruction in HIV/AIDS patients. CJITWM. (2006) 26:319–21.

PubMed Abstract | Google Scholar

88. Mao YX, Niu LN, Zhao XM. Clinical effect of Ailing granule on the treatment of HIV/AIDS patients. Hebei J TCM. (2009) 31:660–2.

Google Scholar

89. Song CX, Wei JA, Huang XZ. Study on the effect of Ailing granule a Chinese medicinal compound on the function of immunological cells in people living with HIV/AIDS. Chin J AIDS STD. (2010) 16:4–7.

Google Scholar

90. Jin Y. Efficacy of Ailing Granules on HAART Clinical Study. China Academy of Chinese Medical Sciences (2007). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAk6X_k1IQGNCLwAgnuJ-hC0_A9T–aEIDBn7uPWk3uQq_Q32XnP1PTtHC4IHvTgsuz&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

91. Chen SS. Clinical Research on the effect of Ailing granule on peripheral blood T cells subsets and Th1/Th2 cells in HIV/AIDS patients. China Academy of Chinese Medical Sciences (2012). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRBJiineKUFiqsBYq8lOYrx7KlTAuH7N13-ff2vxHib9OhXGGBYPhTLWSVbdPvGxerNya20WU8zFbkQjx8IkN-lHKR4Cp_45BL8glAAjLgH5MwoSQt_jXfuaW0dITR1i6fU=&uniplatform=NZKPT&flag=copy (accessed July 31, 2024).

Google Scholar

92. Shen Y. Analysis of the clinical value of Aikang capsule in treating HIV/AIDS patients with spleen and lung weakness syndrome. China Med Phar. (2015) 12:175694444.

Google Scholar

93. Xie SP, Fan WQ, Guo HJ. Study on the effect of Aikang capsule on the immune function of HIV/AIDS patients. Liaoning J Tradit Chin Med. (2008) 35:165–7.

Google Scholar

94. Xie SP, Guo HJ, Xu QL. Effect of “aikang capsule” on life quality in HIV/AIDS patients. SHJTCM. (2007) 41:15–8.

Google Scholar

95. Wang L, He Li S, Yang YQ. Clinical efficacy of Kang'ai Baosheng pill (康爱保生丸) in treatment on 402 cases of HIV/AIDS. Liaoning J Tradit Chin Med. (2021) 48:99–102.

Google Scholar

96. Wang L, He Li S, Yang YQ. A randomized controlled trial of kangai baosheng pills combined with haart in the treatment of AIDS Stage II B patients. Chin J Integr Med. (2022) 41:1306–11.

Google Scholar

97. Li Q. Study on the Immune Function and Retinal Microvascular Disease of Kangaibaosheng pill combined with HAART on HIV Infection. Chengdu University of TCM (2017). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRD2cnxVYBAgfHvJigZmf4sZ65hMoUb3yS1pYmcAyVwJWXjKorjMdTimdz1fEI6IR1ShsMrrpiGo2oxV7_zKLQRXVmkeZPOggc29WP-AUSgyjRjRkI4ZHmpMkYK28whrkrE=&uniplatform=NZKPT&flag=copy (accessed July 31, 2024).

Google Scholar

98. Wen M, Li YP, He LS. Investigating the T lymphocyte subgroups of 126 HIV/AIDS by HAART plus Kangai Baosheng pill. Lishizhen Med Mater Medica Res. (2017) 28:898–900.

Google Scholar

99. Yang SC, Zhao J, Duan CY. A clinical analysis of CD4 count changes of AIDS patients by kangaibaosheng pills combined with HAART. Yunnan J Tradit Chin Med Mater Med. (2012) 33:25–6.

Google Scholar

100. He P, Yang ZQ, Dong JW. Efficacy analysis of kangaibaosheng pills on the treatment of AIDS patients by combining with HAART. Yunnan J Tradit Chin Med Materia Medica. (2012) 33:36–7.

Google Scholar

101. He P, Cheng PH, Li Q. Clinical study on treatment of AIDS with highly effective antiretroviral combined with kangai baosheng pill. Yunnan J Tradit Chin Med Materia Medica. (2023) 44:38–41.

Google Scholar

102. Wang B, Ren TL, Wang CY. Clinical observation on CD4 cell count of 18 cases of HIV-infected patients treated with Kangai Baosheng Pill. Yunnan J Tradit Chin Med and Materia Medica. (2011) 32:48–9.

Google Scholar

103. Tan YX. Research on the intervention effect of Kang'ai BaoshengPills on the Patients with HIV Infection in Qi-yin Deficiency Type. YunNan University of Chinese Traditional Medicine (2017). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRA-TBdxbSW4d8suTt9QgHA5umyT-bWfZC6lonim2GWrSCledwE3VrgSbe_eBrvGdM1q6CrNjWdLpdcbq90uxuc7dCBGvoCvbQS8j63UNSBI6MBYOu6hVw4H_ldLrX8Fpn8=&uniplatform=NZKPT&flag=copy (accessed July 31, 2024).

Google Scholar

104. Sun J, Wang L, He ZZ. Analysis of the curative effect of kangai baosheng pills on HIV/AIDS patients with low CD4/CD8 ratio after HAART. Yunnan J Tradit Chin Med and Materia Medica. (2020) 41:16–9.

Google Scholar

105. Cai Y. Kang ai pill treatment of two routes of infection in HIV/AIDS patients clinical efficacy research. YunNan University of Chinese Traditional Medicine (2012). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAk8URRK9V8kZLG_vkiPpTeIfesrFLO8OHBeYwC1YhmD7XrxJfizyBUpEaQ9ULB9dSJ&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

106. Ba GM. The Observation of the Clinical Effects of Kang'ai BaoshengPills in Treating the Patients with HIV Infection in Plague-poison Containment and Qi-yin Deficiency Type. YunNan University of Chinese Traditional Medicine (2015). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAk6nr4r5tSd-_pTaPGgq4znK9RpTvzE3bo_elo30T77hMTO0DrQhaiRHKkuw9Uz8lv&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

107. Wu H, Zhao M, Li XW. Clinical observation of the efficacy and safety of Aifukang capsule in patients with HIV infections and AIDS. Chin J AIDS STD. (2012) 18:434–7.

Google Scholar

108. Mao J, Wang JW, Chen L. Clinical observation on relieving adverse reaction from HAART in HIV/AIDS patients with the Redu Neiyun syndrome with the Aifukang capsule. Clin J Chin Med. (2017) 9:70–2.

Google Scholar

109. Mao J. Clinical observation on the reduction of toxic side effects of HARRT by Aifukang capsule. Hunan University of Chinese Medicine (2018). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAkWfZcByc-RON98J6vxPv10WSwBFLTvw1fjf1mlxr1RWsfdW56Cb0HhVNChEuCoMhk&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

110. Lin DJ. Clinical study on aifukang capsules combined with HAART for acquired immune deficiency syndrome. J New Chin Med. (2021) 53:95–8.

Google Scholar

111. Wang Q. Research of Fuzheng Anti-Aids Prescription on HIV/AIDS patients in lL-2 and IFN-γ. Hbtcm. (2009). p. 35. Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAk6at-NE8M3PgrTsq96O6n6SIqDMjC3pNkYxYQVY6P5kKgfoLP–_dbv0LjjW67UnZ&uniplatform=NZKPT

Google Scholar

112. Liu JZ. Clinical study on 30 cases of HIV/AIDS treated with “Fu Zheng Anti Aids Formula”. Hbtcm. (2007). p. 105. Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C447WN1SO36whBaOoOkzJ23ELn_-3AAgJ5enmUaXDTPHrI5XBBDOtd9d_usAnurLVhdByzYRTlYBp0CeD3UZDfjJ&uniplatform=NZKPT

Google Scholar

113. Zhao YQ, Liu JZ, Liu J. Clinical study on healthy qi-reinforcing anti-aids granule in treatment of 30 cases with HIV/AIDS. World Chinese Med. (2008) 3:144–6.

Google Scholar

114. Sun JF. Clinical observation of Taiqi Pei-yuan granule combined with highly effective antiretroviral therapy for AIDS patients. Xin Jiang Medical University (2017). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAk-6BvX81hrs37AaEFpExs0Bwu7tKd_WZ0KmwPh1hImvCuSXHHtgfyOh8U45IYukLW&uniplatform=NZKPT

Google Scholar

115. Li XH. Effect of Taiqi Peiyuan Granule on PD-1 expression in HIV/AIDS patients. Xin Jiang Medical University (2022). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAkaWjBDt8_rTOnKA7PWSN5MAgBV8EdPuEy0JYldgr9f0UhRH_1vvQRwO6x0DWuy8WE&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

116. Liang JP. Clinical observation on efficacy and safety of Taiqi Peiyuan granule in treating deficiency of lung and kidney due to deficiency of Qi and Yin. Xin Jiang Medical University (2022). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAkaWjBDt8_rTOnKA7PWSN5MAgBV8EdPuEy7Bpu9DeX_3dmruFmCkJ8gVPQzfBydAhl&uniplatform=NZKPT

Google Scholar

117. Xi RH. Taiqi peiyuan granules adjuvant antiviral regimen clinical study on the treatment of qi and yin deficiency type of AIDS. J Clin Med. (2016) 3:4609–11.

Google Scholar

118. Aihemaiti A, Shu ZJ, Ma JP. Effect of taiqipeiyuan granules on TLR-4 receptor of HIV-infected patients who were deficency of both Qi-yin and Lung-kidney. Chinese J Med Guide. (2017) 19:1373–7.

Google Scholar

119. Wei YY, Ma JP. Observation of Clinical Curative Effect of Taiqipeiyuan Granules to HIV-infected Patients. Chinese J Med Guide. (2017) 19:1378–81.

Google Scholar

120. Aihemaiti A, Ma JP, Sun JF. Safety study of Taiqi Peiyuan Granules in the treatment of HIV-infected patients with qi and yin deficiency, lung and kidney insufficiency type. Xinjiang J Tradit Chin Med. (2016) 34:1–2.

Google Scholar

121. Liu XH, Chen YY, Hou MJ. Effect of taiqi pelyuan granule combined with HAART on lmmune reconstruction inHIV/AIDS patients. Asia-Pacific Tradit Med. (2020) 16:108–11.

Google Scholar

122. Wei YY. The effect of Taiqi Pei-yuan granule on the difference protein of HIV-infected patients. Xin Jiang Medical University (2018). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAkEcTGK3Qt5VuzQzk0e7M1z82q_WNMtJ1MBXZiiuWwVpXu3D8TzU_DzZAEndA_yj9u&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

123. Wang J, Li Y, Tang YL. Clinical trial of the effect of Immune No. 1 on immune functions of HIV infectors. Chin J AIDS STD. (2012) 18:356–9.

Google Scholar

124. Wu XF. Effect of Combination of Immune I and HAART on Immune Function and Immune Activation of HIV/AIDS Patients. China Academy of Chinese Medical Sciences (2011). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C447WN1SO36whNHQvLEhcOy4v9J5uF5Ohrl8vTzlaZqhNhF-7hZsVngbHVAPhgMPjGfox8BdeChfSzp7mSf305De&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

125. Wang J, Lin HS Li Y. Effect of Mianyi No. 2 formula on the symptoms and signs of HIV/AIDS patients with insufficient immune reconstitution. J Tradit Chin Med. (2012) 53:923–6.

Google Scholar

126. Tang YL. Effect and related mechanisr of Mianyi No.2 on the Immune Reconstitution in Patients with AIDS after HAART. BUCM (2012). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C447WN1SO36whHG-SvTYjkCc7dJWN_daf9c2-IbmsiYfKoZDfdXClyVT27UgA-dTYlTZpaHLEEpk-9weDH0LUAFo&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

127. Liu Y, Wang J, Zou W. Effect of immune No. 2 granule on CD4+ counts of AIDS patients with immune reconstitution deficiency after HAART. J Tradit Chin Med. (2017) 58:34–7.

Google Scholar

128. Ying L, Wen Z, Qingfei X. Efficacy and safety of Mianyi granules for reversal of immune nonresponse following antiretroviral therapy of human immunodeficiency virus-1:a randomized, double-blind, multi-center, placebo-controlled trial. J Tradit Chin Med. (2022) 42:432–8.

PubMed Abstract | Google Scholar

129. Liu Z, Wang J, Lin HS. Effect of Immune 2 with highly active antiretroviral treatment on immune function of HIV/AIDS patients with poor immune reconstitution. China J Chin Mater Medica. (2013) 38:2458–62.

Google Scholar

130. Lu ZY, Nai X, Wang L. Clinical study on the treatment of dyslipidaemia in human immunodeficiency virus infection/AIDS by combination of Yi Chen San and Er Chen Tang. Lishizhen Med Mater Med. (2021) 32:903–4.

Google Scholar

131. Zhan L, Yue ST, Xue YX, Attele AS, Yuan CS. Effects of qian-kun-nin, a Chinese herbal medicine formulation, on HIV positive subjects: a pilot study. Am J Chin Med. (2000) 28:305–12. doi: 10.1142/S0192415X00000362

PubMed Abstract | Crossref Full Text | Google Scholar

132. Liu G, Qin GM, Liu XY. Analysis of therapy effect of Chinese medicine ‘qiankunning' on AIDS. Modern Prev Med. (2004) 31:245–8.

PubMed Abstract | Google Scholar

133. Chen RF, Yang QE, Xu SF. Clinical analysis of chaste astragali fuzheng capsule combined with HAART in the treatment of AIDS. Mod J Integr Tradit Chin Western Med. (2014) 23:2664–5.

Google Scholar

134. Zhang JS. The study on mitochondrial DNA poly- morphism of HIV/AIDS patients and effect of Zhen Qi Fuzheng granule on immune reconstitution of patients. Southern Medical University (2017). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRBnQwcWdPxDbSqq6EVi51qX6iptM7k368w_eAX5w1Gq8lErP_KNEN7C6DMLdeAltXoEJ6COKYKKZ39ujsalnYPiwDVLmeiF566DmT6QAIooAB9xalCTvdIAvlBNbKk2aepzzcn_t1bG7Q==&uniplatform=NZKPT&language=CHS (accessed July 31, 2024).

Google Scholar

135. Maek-a-nantawat W, Phonrat B, Dhitavat J. Safety and efficacy of CKBM-A01, a Chinese herbal medicine, among asymptomatic HIV patients. Southeast Asian J Trop Med Public Health. (2009) 40:494–501.

PubMed Abstract | Google Scholar

136. Burack JH, Cohen MR, Hahn JA, Abrams DI. Pilot randomized controlled trial of Chinese herbal treatment for HIV-associated symptoms. J Acquir Immune Defic Syndr Hum Retrovirol. (1996) 12:386–93. doi: 10.1097/00042560-199608010-00009

PubMed Abstract | Crossref Full Text | Google Scholar

137. Yang WX, Kang LY, Pan QC. Preliminary study on therapeutic effect of XQ-9302 chinese herbal preparation to AIDS. shanghai J Tradit Chin Med. (1999) 1:3–7.

Google Scholar

138. Li XW. The Reserch of ZL-1 Capsule for HIV in Efficacy and Safety. Guangzhou University of Chinese Medicine (2013). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAkueNJRSNVX-zc5TVHKmDNksxcYMMtrqIUizLClzTm-miax9QohVmBHMqYZbAKKQIi&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

139. Wang J, Yang FZ, Zhao M. Randomized double-blinded and controlled clinical trial on treatment of HIV/AIDS by Zhongyan-4. Chin J Integr Med. (2006) 12:6–11. doi: 10.1007/BF02857422

PubMed Abstract | Crossref Full Text | Google Scholar

140. Yang ZH. A Clinical Study on Wenbu Pishen Granules Reversing the Hematotoxicity Caused by HAART to HIV/AIDS Patients. Guangzhou University of Chinese Medicine (2012). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAkWGEmc0QetxDh64Dt3veMp0KVv6OczLE1jCWkZRyhnx7g7LptEO1EiDCQPnziaYwW&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

141. Zhuang T, Jian W, Xin C. Wenshen Jianpi recipe induced immune reconstruction and redistribution of natural killer cell subsets in immunological non-responders of human immunodeficiency virus/acquired immune deficiency syndrome: a randomized controlled trial. J Tradit Chin Med. (2022) 42:795–802.

PubMed Abstract | Google Scholar

142. Xiao TY. Clinical study on treatment of senile HIV/AIDS (Yang deficiency and dampness stagnation type) with warming yang, invigorating spleen and resolving dampness method. YunNan University of Chinese Traditional Medicine (2021). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAkueNJRSNVX-zc5TVHKmDNkrQ0wS3LpUJVnaCHqM0G50UkdHfZhDBiUh7PtvKpFxUY&uniplatform=NZKPT

Google Scholar

143. Peng XX. The effect of Xiang A1 particles combined with HAART treatment on Th1/Th2 peripheral blood immune factors in patients with H I V/AIDS with spleen deficiency. Hunan University of Chinese Medicine (2022). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRCvKYz1UTtbwByi2yQCEbRhPjzBlfgxWafDhvZaoA2-dZmcziCdDO1WrW_bJCguGWBvWknPblezzEGGqNkfSMOoRiwgAc68iUITFXPp2Xjroh3njGMjbdnnpqw9OCEz3O_rc0cGGbp6sg==&uniplatform=NZKPT&language=CHS (accessed July 31, 2024).

Google Scholar

144. Lv WB, Tang JJ, Huang RZ. Clinical observation on 43 HIV/AIDS patients treated with new century Kangbao. J Chin AIDS/STD Prev Cont. (2000) 3:168–9.

Google Scholar

145. Zhao HX, Zhang FJ, Gao GJ. A 24 week chinical observation on the officaoy and safety of a domestic generic ARV drug combined with the Chinese treating medicine in the treatment of HIV/AIDS patients. Chin J AIDS STD. (2006) 4:297–316.

Google Scholar

146. Chen S, Xu Q, Wang J, Tan X. Effects of artesunate tablet on immune activation and reconstitution among highly active antiretroviral therapy-treated patients with incomplete immune responses. AIDS Res Hum Retroviruses. (2022) 38:100–10. doi: 10.1089/aid.2020.0254

PubMed Abstract | Crossref Full Text | Google Scholar

147. Liang Y. Document & Preliminary Clinical Study On Anti-HIV Tradit Chin Medicine. China Academy of Chinese Medical Sciences (2019). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=PhqKDHt8vRA2qx3AgmjG-KQCYMjvj6GLsdlcxbGONXhQr2xqzg53TETu5w8JC_-cxN533z1CPsXcqaNORJGZaZAL9b-tDLnbH-2pUQfyzNakNBDfXxKfX2PWbHPegRkgBvV3O-AABhqOGeI60NPzCg==&uniplatform=NZKPT&language=CHS (accessed July 31, 2024).

Google Scholar

148. Zhang YL, Zhang TY, Chen JS. Clinical observation on the treatment of AIDS with Shuanghuanglian powder injection. J Shanxi Med Univ. (1999) 2:84–6.

Google Scholar

149. Tian ZW, Sing XF, Feng J. Clinical Research of Treatment on HIV/AIDS with Traditional Chinese Medicine. Lishizhen Med Mater Medica Res. (2005) 04:344–6.

Google Scholar

150. Liu M, Zheng YH, Zhou HY. Evaluation of the curative efficacy and safety of compound astragalus mongholicus granule in patients infected with HIV. Chin J Infect Control. (2009) 8:21–4.

Google Scholar

151. Miao H. The clinical research of Fu Fang Qi Shu decoction combined with highly active antiretroviral therapy treating AIDS in type of spleen-insufficiency with dampness-overabundance. Fu Dan University (2014). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAk6nr4r5tSd-_pTaPGgq4znGd3WIUAGVZwuup1leqocgT3SKGSpDBO2s4OGckZYgE5&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

152. Zhao P, Zhang X, Zhao H. Clinical observations on HIV/AIDS treated with Chinese herb combination Sanhuang capsule. Mod J Integr Trad Chin Western Med. (2011) 20:4193–7.

Google Scholar

153. Liu X, Lin L, Lv T. Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders. Phytomedicine. (2022) 101:154103. doi: 10.1016/j.phymed.2022.154103

PubMed Abstract | Crossref Full Text | Google Scholar

154. Bai WS Li B, Nao M. Observation on the clinical efficacy of Aining particle in treating HIV/AIDS patients of Tanzania. China J Chin Med. (2012) 27:131–3.

Google Scholar

155. Su QJ, Song C, Lu ZZ, Liu ZW, Xiao J, Wu FS. Impact of herbal preparations on outcomes of highly active antiretroviral therapy: a one-year prospective cohort study. Chin J Integr Med. (2020) 26:497–501. doi: 10.1007/s11655-019-3156-x

PubMed Abstract | Crossref Full Text | Google Scholar

156. Zhang ML. A before-after self-controlled study on the efficacy of Different formulations of Fu Yang Jie Du preparation to HIV Infectors. Chengdu University of TCM (2014). Available online at: https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C475KOm_zrgu4lQARvep2SAkbl4wwVeJ9RmnJRGnwiiNVkt9vD5xY0st0PlUDnIiVqS2s_eJaLTzYmBYDO1_fhYX&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

157. Li LP, Xu LR, Fu W. Long - term effect of TCM comprehensive intervention on HIV/AIDS patients' immune function and opportunistic infections. ACTA Chin Med. (2016) 1:1–3.

Google Scholar

158. Qian JY, Sang F, Liu Z. Effects of Yi Ai Kang serum on the apoptosis of NK-92MI cells and the expression of NKG2A, NKG2D and IFN-γ. China J Tradit Chin Med Phar. (2021) 36:6756–9.

Google Scholar

159. Zhao ML, Wang QO, Liu BB. Experimental study on treatment of SIV infected rhesus monkeys AIDS model by Yiaikang combined with ART. Liaoning J Tradit Chin Med. (2023) 50:193–8.

Google Scholar

160. Xu LR, Chen GZ, Li H. Discussion on “Spleen as the Pivot” in Chinese Medicine of AIDS. TCM Res. (2010) 123:1–3.

Google Scholar

161. Peng B, Miao MS, Guo HJ. Effect of Fuzheng Paidu tablet on the immune function of mice with immunosuppr ession induced by cyclophosphamide. Chin J Clin Rehabilit. (2006) 10:126–8.

Google Scholar

162. Shi JJ, Shi B, Miao MS. Immunoregulatory Effects of Fuzheng Paidu Tablets on T Lymphocytes and Immune Organs in Mice. World Sci Technol Modern Tradit Chin Med Materia Medica. (2016) 18:457–63.

Google Scholar

163. Liu J. Study on the effects of Fu Zheng Anti Ai Formula on immunomodulation and CC and CXC chemokines in immunosuppressed mice. Hbtcm (2007). Available online at: ttps://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C447WN1SO36whBaOoOkzJ23ELn_-3AAgJ5enmUaXDTPHrJVcfWP3-8X2TIQJqc3PKSn5hO5khWUAd5f0upmYst51&uniplatform=NZKPT (accessed July 31, 2024).

Google Scholar

164. Zeng L, Ma XL, Ma JP. Effects of taiqi peiyuan granule on T cell subsets, NK cell count and macrophage phagocytosis in immunosuppressive mice. J Basic Chin Med. (2021) 27:939–43.

Google Scholar

165. Tang YL, Wang J, Li Y. Changes on Toll-like receptor signalling pathway of AIDS patients with incomplete immune reconstitution and the infl uence of Immune No. 2 by gene chip technology. CJTCMP. (2012) 27:789–93.

Google Scholar

166. Ma X, Ma JP, Zhang Y. Study on Vitro Anti-HIV-2 Activity of Taiqi Peiyuan Granules. Chinese J Inf Tradit Chin Med. (2016) 23:61–3.

Google Scholar

167. Yao JY, Deng BW Li CC. Effects of Yiaikang Capsule on the tight junction of IFN-γ-induced intestinal mucosal barrier and the expression of relaxed proteins Claudin-1 and Claudin-5. Chin J Hosp Pharm. (2020) 40:897–901.

Google Scholar

168. Shen JL, Ren ZX Li Q. Effects of iacosan-containing serum on genes related to lipid metabolism in ritonavir-induced HepG2 cells. Lishizhen Med Materia Med. (2019) 30:77–80.

Google Scholar

169. Sang F, Li Q, Qian JY. Discussion on the protective effect of yiaikang capsule on intestinal mucosal barrier injury of HIV/AIDS based on permeability and tight junction. JETCM. (2018) 27:769–72.

Google Scholar

170. Elim HL, Mapanawang AL. The attractive difference s of two types of herbal medicine from zingiberacea fruit (golobe halmahera). Int J Health Med Current Res. (2018) 3:826–34.

Google Scholar

171. Mapanawang AL, Elim HL. Pangi Leaf (Pangium edule Reinw) herbal medicine:a marvelous candidate for the prominent HIV herbal medicine. Sci Nat. (2019) 2:97–104. doi: 10.30598/SNvol2iss2pp097-104year2019

Crossref Full Text | Google Scholar

172. Mapanawang AL, Elim HI. Unique chemical bonding behavior of love herbal medicine and its ability as a chemotherapy drug. J Nanomed Nanotechnol. (2018) 9:503. doi: 10.4172/2157-7439.1000503

Crossref Full Text | Google Scholar